sec whistleblower attorneys
June 05, 2020
Stiefel Laboratories Inc., Charles W. Stiefel
Trading and Pricing
SANCTION AMOUNT: $37000000
Defendants: Stiefel Laboratories Inc.
Charles W. Stiefel
Company and its former Chairman/CEO consented to entry of final judgment in case alleging that they conducted share buybacks (mostly from employees) without disclosing negotiations with GlaxoSmithKline PLC that resulted in an acquisition at a share price more than four times higher than the buyback price.
- Key Docs
- Official SEC press release
